 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2025 |
|
 |
|
JORD BIOSCIENCE APPOINTS ROB DEWOLFE AS CFO, ACCELERATING GROWTH IN MICROBIAL AGRICULTURAL SOLUTIONS
Apr. 3, 2025
Source: Jord BioScience news release
 |
|---|
| Rob DeWolf |
MINNEAPOLIS, MN, - Jord BioScience, a leading science and analytics company providing customizable microbial solutions for agriculture, has appointed Rob DeWolfe as Chief Financial and Operating Officer, bolstering its leadership team following a successful Series B funding round.
DeWolfe brings over 25 years of experience in finance, operations, and business technology to Jord BioScience. His expertise in optimizing processes, enhancing profitability, and implementing data-driven strategies will be crucial as the company enters its next growth phase.
"After working closely with Rob over the past year, it was clear his expertise and perspective complement our leadership team in ways that will be instrumental as we continue to execute our growth strategy and expand our portfolio of microbial technologies to deliver next-generation crop inputs," said Dr. Keri Carstens, president and CEO, Jord BioScience. "In addition to our exclusive biological playbook and microbial library, our people make Jord BioScience a stand-out company - and we're thrilled to have Rob on the team."
DeWolfe was most recently a partner at Growth Operators, a firm specializing in finance and human resources in Minneapolis, Minn. He began his career in accounting before transitioning into senior management roles across various industries, with a focus on financial planning, demand and inventory planning, category management, and sales/marketing analysis. His ability to bridge the gap between business and technology has made him a sought-after expert in developing efficient systems and data-driven strategies that empower scale-up organizations to thrive in a competitive marketplace.
"I'm excited to join a team committed to scientific innovation and creating real change in an industry that urgently needs new solutions to feed the world," DeWolfe said.
Following a successful Series B announcement, Jord BioScience is scaling research and partnerships in the U.S. and internationally to help biologicals and crop inputs companies accelerate product discovery and innovation for farmers worldwide.
For more information about Jord BioScience, visit jordbioscience.com.
About Jord BioScience
Jord BioScience, founded on research from the University of Minnesota, is a science and analytics company developing cutting-edge microbial technologies to enhance crop productivity and sustainability in agriculture. The company leverages over three decades of research by Dr. Linda Kinkel and her team, who collected thousands of unique soil microbes globally. Jord's proprietary technology and custom formulations are designed to extend product lifecycles, enhance crop performance, and expand market adoption of microbial solutions. From product concept through commercialization, Jord BioScience fast-tracks novel product development, reducing discovery from years to less than 10 months. This approach maximizes value and results in today's competitive marketplace. The company is currently conducting product development trials in the U.S., Argentina, and Brazil.
|
|
|
|
|
